← Current compounder rows

Current NDC auxiliary source row compounder:3030

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source
ndc_compounder_zip
Product Ndc Raw
71139-5355
Product Ndc
71139-5355
Product Ndc Digits
711395355
Product Type Name
HUMAN COMPOUNDED DRUG
Proprietary Name
Sugammadex
Proprietary Name Suffix
[empty]
Nonproprietary Name
Sugammadex
Dosage Form Name
INJECTION
Route Name
INTRAVENOUS
Marketing Category Name
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name
IntegraDose Compounding Services, LLC
Establishment Name
IntegraDose Compounding Services, LLC
Establishment Fei
[empty]
Substance Name
SUGAMMADEX
Active Ingredients Info
200 mg/2 mL
History Active Ingredients Raw
SUGAMMADEX
History Active Ingredients Info Raw
200 mg/2 mL
History Dosage Raw
INJECTION
Dea Schedule
[empty]
Package Ndc Raw
71139-5355-1
Package Ndc
71139-5355-1
Package Ndc Digits
7113953551
Package Ndc11
71139535501
Package Description
2 mL in 1 SYRINGE (71139-5355-1)
Reporting Period Raw
2024-2
Reporting Period
2024-2
Normalization Status
valid
Source Url
https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive
compounders_ndc_directory.zip
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Last Modified
Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256
222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256
f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id
compounder:3030
Source Row Number
3030
Source Row Hash
e127229bdb7323fbef5ff9549172d0c2050d91fc22b9d0eaac386d2e28546aa9
Import Run Id
20261119T172627Z
Loaded At
2026-11-19 17:42:45

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAVENOUS",
    "PRODUCTNDC": "71139-5355",
    "DEASCHEDULE": "",
    "LABELERNAME": "IntegraDose Compounding Services, LLC",
    "SUBSTANCENAME": "SUGAMMADEX",
    "DOSAGEFORMNAME": "INJECTION",
    "NDCPACKAGECODE": "71139-5355-1",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Sugammadex",
    "REPORTINGPERIOD": "2024-2",
    "NONPROPRIETARYNAME": "Sugammadex",
    "PACKAGEDESCRIPTION": "2 mL in 1 SYRINGE (71139-5355-1) ",
    "ACTIVEINGREDIENTSINFO": "200 mg/2 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset
compounder
Record Source
ndc_compounder_zip
Source Record Id
compounder:3030
Source Row Number
3030
Status Scope
package
Lookup Ndc
71139-5355-1
Lookup Ndc Digits
7113953551
Product Ndc
71139-5355
Product Ndc Digits
711395355
Package Ndc
71139-5355-1
Package Ndc Digits
7113953551
Package Ndc11
71139535501
Product Id
[empty]
Status Code
COMPOUNDER
Status Label
Outsourcing facility compounded drug report
Reporting Period Raw
2024-2
Reporting Period
2024-2
Source Table
fda_ndc_aux_compounder
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Row Hash
e127229bdb7323fbef5ff9549172d0c2050d91fc22b9d0eaac386d2e28546aa9
Import Run Id
20261119T172627Z
Loaded At
2026-11-19 17:42:45